News Daily News Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression Michael O'Riordan August 08, 2022
News Daily News Early LV Recovery After TAVI Points to Better 5-Year Survival Yael L. Maxwell August 01, 2022
News Daily News Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’ Michael O'Riordan July 18, 2022
News Daily News Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach Michael O'Riordan June 21, 2022
News Daily News Subclinical Thrombosis After TAVI Benign, at Least to 3 Years Michael O'Riordan June 07, 2022
News Daily News NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes L.A. McKeown May 03, 2022
News Daily News The NCDR Has Made a Difference, but Experts See Room for Growth Todd Neale April 28, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Daily News ‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible Michael O'Riordan March 21, 2022
News Daily News Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients Todd Neale March 16, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Daily News Good Results For TAVI in Bicuspid Valves, but Questions Persist Michael O'Riordan March 08, 2022
News Daily News Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients Michael O'Riordan February 25, 2022
News Daily News ‘Considerable’ Aortic Stenosis Burden in UK Begs Money and a Plan Michael O'Riordan January 28, 2022
News Daily News Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps Caitlin E. Cox January 25, 2022
News Daily News Lower Costs for TAVI Valves Could Improve Access, Analysis Hints Yael L. Maxwell January 24, 2022
News Daily News ‘Home Time’ Validated as TAVI Outcomes Performance Metric L.A. McKeown January 11, 2022
News Daily News Studies Zero in on Delayed Conduction Problems After TAVI Todd Neale December 21, 2021
News Daily News SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS L.A. McKeown November 30, 2021